Login to Your Account



Pharma: Other News To Note


Wednesday, April 10, 2013
• Ipsen SA, of Paris, said Health Canada granted marketing authorization for Dysport (botulinum toxin Type A for injection) for the temporary improvement in the appearance of moderate to severe frown lines in adults younger than 65.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription